Antimony-resistant Leishmania donovani in eastern Sudan: Incidence and in vitro correlation

Eastern Mediterranean Health Journal

Volumn 9, Issue 4, 2003, Pages 837-843

  Abdo, M G ^a   Elamin, W M ^a   Khalil, E A G ^a   Mukhtar, M M ^a  

^a UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY; DNA; RESTRICTION ENDONUCLEASE; STIBOGLUCONATE SODIUM;

ADOLESCENT; ADULT; AMASTIGOTE; ANIMAL CELL; ARTICLE; CHI SQUARE TEST; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDEMIC DISEASE; FEMALE; HUMAN; IN VITRO STUDY; INCIDENCE; LEISHMANIA DONOVANI; LONGITUDINAL STUDY; LYMPH NODE BIOPSY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PARASITE ISOLATION; POLYMERASE CHAIN REACTION; SUDAN; TREATMENT FAILURE; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; DNA, KINETOPLAST; DNA, PROTOZOAN; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; ENDEMIC DISEASES; FEMALE; HUMANS; INCIDENCE; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LONGITUDINAL STUDIES; LYMPH NODES; MALE; MIDDLE AGED; PARASITIC SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SUDAN; TIME FACTORS; TREATMENT FAILURE;

EID: 16844369135     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Olliaro PC, Bryceson ADM. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitology today, 1993, 9:323-8.
2. Murray HW et al. Interleukin-12 regulates the response to chemotherapy in experimental visceral leishmaniasis. Journal of infectious diseases, 2000, 182(5):1497-502.
3. Lira R et al. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. Journal of infectious diseases, 1999, 180(2):564-7.
4. Khalil EAG et al. Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1996, 90(2):187-8.
5. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clinical infectious diseases, 1997, 24(4): 684-703.
6. Peters BS et al. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Quarterly journal of medicine, 1990, 77(283):1101-11.
7. Faraut-Gambarelli F et al. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrobial agents and chemotherapy, 1997, 41(4): 827-30.
8. Rosenthal E et al. Visceral leishmaniasis and HIV-1 co-infection in Southern France. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1995, 89(2):159-62.
9. Berenguer J et al. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Annals of internal medicine, 1989, 111(2):129-32.
10. Evans TG. Leishmaniasis. Infectious disease clinics of North America, 1993, 7(3):527-46.
11. Smyth AJ et al. Rapid and sensitive detection of Leishmania kinetoplast DNA from spleen and blood samples of kalaazar patients. Parasitology, 1992, 105(2): 183-92.
12. Zijlstra EE et al. Endemic kala azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical disease and post kala azar dermal leishmaniasis. American journal of tropical medicine and hygiene, 1994, 51(6): 826-36.
13. Dereure J et al. Visceral leishmaniasis in eastern Sudan: parasite identification in humans and dogs. Host-parasite relationship. Microbes and infection, 2003, 5(12):1103-8.
14. Basselin M, Badet-Denisot MA, Robert-Gero M. Modification of kinetoplast DNA minicircle composition in pentamidine-resistant Leishmania. Acta tropica, 1998, 70(1):43-61.
15. Ibrahim ME et al. Leishmania resistant to sodium stibogluconate: drug associated macrophage dependent killing. Parasitology research, 1994, 80(7):569-74.